With great zeal, PharmaShots began an Exclusive Video Interview series for C-suites. An innovative idea to bring thought leaders of the industry, our Exclusive Video Interview offering is a noble initiative by PharmaShots to capture the developments of leading companies. As a part of offering, PharmaShots will be publishing exclusive video interviews every second Monday…
Following the Reuters Events Pharma USA 2024, PharmaShots brings an engaging conversation with Moreno Perugini, President, of Néstle Health Science. Moreno begins the conversation by highlighting Néstle’s journey to become a full-fledged pharma company through a series of acquisitions and deals.
Moreno recalls Néstle’s transitioning into a pharmaceutical company when the company got the rights for Zenpep,…
Shots:
Our recent Spotlight interview with David Esposito, CEO at ONL therapeutics became a major hit on the internet. We were moved by the overwhelming response from the netizens
Here we have again, David Esposito in an engaging conversation with PharmaShots. David discusses in great length about the company’s lead candidate ONL1204, currently being evaluated…
Shots:
In an extended cut to our Spotlight Interview, PharmaShots presents an exclusive interview session with David A. Dodd, Chairman, President, and CEO at GeoVax labs
David speaks about the company’s rich history and highlights the journey through the years and the strategic shift from being a single-focus HIV vaccine developing company to an infectious…
Spotlight Interview: David A. Dodd, CEO at GeoVax Labs, in an Engaging Conversation with PharmaShots
PharmaShots’ Spotlight offers a unique platform for biopharma, life sciences, and healthcare companies, allowing them to connect with their target audiences and like-minded people.
This week at the Spotlight, we had a riveting discussion with David A. Dodd, Chairman, President & CEO, at GeoVax Labs.
David eloquently highlighted GeoVax’s extraordinary journey over the years from…
“Spotlight-Company of the Month” offers a unique platform for biopharma, life sciences, and healthcare companies, allowing them to connect with their target audiences and like-minded people.
This month at PharmaShots’ Spotlight, we had an opportunity to engage in conversation with David Esposito CEO at ONL Therapeutics.
David discusses the company's lead candidate ONL1204, which is…

